European Commission - Statement by President von der Leyen on CureVac Page contents

16 November 2020 |

"The coronavirus continues to spread rapidly across Europe. We need a safe and effective vaccine to end this pandemic. A few days after our contract with BioNTech and Pfizer, I am happy to announce a new agreement. Tomorrow, we will authorise a new contract to secure another COVID-19 vaccine for Europeans. This contract allows us to buy up to 405 million doses of a vaccine produced by the European company CureVac."

Read more at the link below.

RELATED LINKS

About Us
Profile
Board of Directors
Stakeholder Network
Contact

LOGIN